Showing results (21-30 of 66) with videos related to
Sort By:
Pageof 7
Disease Markers|August 1, 2012
Paraoxonase-1 is not associated with coronary artery calcification in type 2 diabetes: results from the PREDICT studyBharti Mackness, Judit Marsillach, Robert S Elkeles, et al.Annals of Clinical Biochemistry|June 3, 2009
Variability in the measurement of lipoprotein(a) in the British IslesMike Mackness, Elizabeth Hughes, European Journal of Clinical Investigation|October 23, 2010
Immunohistochemical analysis of paraoxonases-1 and 3 in human atheromatous plaquesJudit Marsillach, Jordi Camps, Raul Beltran-Debón, et al.Current Opinion in Lipidology|June 4, 2020
Epigenetics of paraoxonasesAbdolkarim Mahrooz, Mike MacknessAtherosclerosis|September 6, 2005
High C-reactive protein and low paraoxonase1 in diabetes as risk factors for coronary heart diseaseBharti Mackness, David Hine, Patrick McElduff, et al.Current Opinion in Lipidology|August 2, 2002
The paraoxonase gene family and coronary heart diseaseBharti Mackness, Paul N Durrington, Michael I MacknessAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 3, 2004
The role of paraoxonase 1 activity in cardiovascular disease: potential for therapeutic interventionMichael I Mackness, Paul N Durrington, Bharti MacknessAtherosclerosis. Supplements|February 8, 2003
Paraoxonase and coronary heart diseaseMichael I Mackness, Bharti Mackness, Paul N DurringtonOccupational and Environmental Medicine|October 6, 2010
'Dippers' flu' and its relationship to PON1 polymorphismsNicola Cherry, Michael Mackness, Bharti Mackness, et al.Circulation|November 10, 2004
Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant miceWim Verreth, Dieuwke De Keyzer, Michel Pelat, et al.Pageof 7